‘We dodged a bullet’: Biotech and pharma react to selection of Marty Makary for FDA commissioner
It is fair to say that far more individuals aside from the commissioner are instrumental as far as the drug review and approval process in the U.S., but Makary we expect will promote technology and innovation in a way that offers some reprieve for those that feared a department more aligned with different virtues.